Evaluation of soft tissue coverage over porous polymethylmethacrylate space maintainers within nonhealing alveolar bone defects.
Current treatment of traumatic craniofacial injuries often involves early free tissue transfer, even if the recipient site is contaminated or lacks soft tissue coverage. There are no current tissue engineering strategies to definitively regenerate tissues in such an environment at an early time point. For a tissue engineering approach to be employed in the treatment of such injuries, a two-stage approach could potentially be used. The present study describes methods for fabrication, characterization, and processing of porous polymethylmethacrylate (PMMA) space maintainers for temporary retention of space in bony craniofacial defects. Carboxymethylcellulose hydrogels were used as a porogen. Implants with controlled porosity and pore interconnectivity were fabricated by varying the ratio of hydrogel:polymer and the amount of carboxymethylcellulose within the hydrogel. The in vivo tissue response to the implants was observed by implanting solid, low-porosity, and high-porosity implants (n = 6) within a nonhealing rabbit mandibular defect that included an oral mucosal defect to allow open communication between the oral cavity and the mandibular defect. Oral mucosal wound healing was observed after 12 weeks and was complete in 3/6 defects filled with solid PMMA implants and 5/6 defects filled with either a low- or high-porosity PMMA implant. The tissue response around and within the pores of the two formulations of porous implants tested in vivo was characterized, with the low-porosity implants surrounded by a minimal but well-formed fibrous capsule in contrast to the high-porosity implants, which were surrounded and invaded by almost exclusively inflammatory tissue. On the basis of these results, PMMA implants with limited porosity hold promise for temporary implantation and space maintenance within clean/contaminated bone defects.
Department of Bioengineering, Rice University, Houston, Texas, USA.
James D
JD
Kretlow
Meng
M
Shi
Simon
S
Young
Patrick P
PP
Spicer
Nagi
N
Demian
John A
JA
Jansen
Mark E
ME
Wong
F Kurtis
FK
Kasper
Antonios G
AG
Mikos
D016301:Alveolar Bone Loss / Q000628:therapy*; D000818:Animals; D008297:Male; D019904:Polymethyl Methacrylate / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D016062:Porosity; D019736:Prostheses and Implants; D011817:Rabbits; D012879:Skin Physiological Phenomena; D017695:Soft Tissue Injuries / Q000628:therapy*; D013499:Surface Properties; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds / Q000737:chemistry*; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology
D019904:Polymethyl Methacrylate